What is benign prostatic hyperplasia, the condition for which King Charles III will have to operate? It is a condition characterized by the increase in volume of the prostate gland and is not a malignant neoplasm.
In fact, the increase in volume is not due to hypertrophy but to hyperplasia of the parenchymal and stromal component of the gland. It generally begins with the development of microscopic nodules made up mainly of stromal and parenchymal elements, which over the years, increasing in number and size, compress and distort the prostatic urethra producing an obstruction that hinders the flow of urine.
What are the symptoms?
Clinical manifestations do not correlate with gland size. a small prostate can cause much more severe obstructive symptoms than a larger prostate. The symptomatology in fact derives from the sum of two components: the static one, determined by the mass of the gland, and the dynamic one, due to the tone of the smooth muscles of the bladder neck, the prostate and its capsule.
The symptoms are of two types. The obstructive urinary ones, and the irritative ones. Obstructive symptoms include difficulty in starting urination, intermittent flow, incomplete emptying of the bladder, weak urinary flow and effort in urination.
Irritative symptoms include frequency of urination, nocturia, i.e. an increased need during the night, the urgent need to empty the bladder and burning sensation when urinating.
After the age of 50, an annual urological examination is recommended. In some patients, hyperplastic evolution of the prostate tissue can begin already after the age of 30. Approximately 50% of men over the age of 60 show signs of BPH; the percentage reaches 90% in patients aged greater than or equal to 85 years.
A urological visit is also indicated in case of persistent urination disorders. Ascertaining the cause of urination disorders in the initial phase allows us to intervene promptly to avoid or at least slow down the progression of the disease towards a clinical picture that could have serious repercussions on the personal and social life of the individual.
In this regard, it must be taken into consideration that, although BPH does not evolve into prostate cancer - the two pathologies develop in different locations of the gland - their coexistence is possible. Ascertaining the origin of any symptoms of the lower urinary tract therefore also serves to exclude or ascertain the possible presence of prostate cancer.